fosaprepitant dimeglumine · Steriscience · NDA 216686
Focinvez
Earliest generic entry, as listed
11 Jan 2039
Blocked by patent: US 11065265, US 12042504.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11065265 | drug product · sets the listed date | 11 Jan 2039 |
| US 12042504 | drug product · sets the listed date | 11 Jan 2039 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 216686 · 001 · RLD | solution, intravenous | EQ 150MG BASE/50ML (EQ 3MG BASE/ML) | 11 Jan 2039 |